By considering the SARS-CoV-2 T cell epitopes and the HLAs that are associated with protection against, and/or associated with susceptibility/severity to SARS-CoV-2 infection; the future COVID-19 vaccine design is expected to be developed based on the non-spike proteins such as NP, M, and ORFs. Here, HLA-S is linked to COVID-19.